The Mechanisms of Cerebral Vascular Dysfunction and Neuroinflammation by MMP-Mediated Degradation of VEGFR-2 in Alcohol Ingestion

Activation of Peroxisome Proliferator-Activated Receptor   (PPAR ) Suppresses Rho GTPases in Human Brain Microvascular Endothelial Cells and Inhibits Adhesion and Transendothelial Migration of HIV-1 Infected Monocytes

(2014) S. H. Ramirez et al.   JOURNAL OF IMMUNOLOGY

Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions

(2011) María I. Gaitán et al.   ANNALS OF NEUROLOGY

The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components

(2011) Saleena Alikunju et al.   BRAIN BEHAVIOR AND IMMUNITY

Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment

(2011) Masato Kanazawa et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Epileptiform Activity Induces Vascular Remodeling and Zonula Occludens 1 Downregulation in Organotypic Hippocampal Cultures: Role of VEGF Signaling Pathways

(2011) M. Morin-Brureau et al.   JOURNAL OF NEUROSCIENCE

VEGFR2 Translocates to the Nucleus to Regulate Its Own Transcription

(2011) Inês Domingues et al.   PLoS One

Serum levels of vascular endothelial growth factor A increase during alcohol withdrawal

(2010) Annemarie Heberlein et al.   ADDICTION BIOLOGY

Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE

(2010) Jami Bennett et al.   JOURNAL OF NEUROIMMUNOLOGY

Enhanced Matrix Metalloproteinase Activity in the Spontaneously Hypertensive Rat: VEGFR-2 Cleavage, Endothelial Apoptosis, and Capillary Rarefaction

(2010) Edward D. Tran et al.   JOURNAL OF VASCULAR RESEARCH

Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells

(2010) Sylvie Lamy et al.   VASCULAR PHARMACOLOGY

Lacunar stroke is associated with diffuse blood-brain barrier dysfunction

(2009) Joanna M. Wardlaw et al.   ANNALS OF NEUROLOGY

VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration

(2009) E. Ugarte-Berzal et al.   BLOOD

Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage

(2009) T. Deguchi et al.   DIABETIC MEDICINE

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

(2009) Azeb Tadesse Argaw et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis

(2008) Erin E. McCandless et al.   AMERICAN JOURNAL OF PATHOLOGY

Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells

(2008) Katherine A. Radek et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells

(2008) T.-K. Ito et al.   BLOOD

Effects of VEGF on the Blood-Brain Barrier Disruption Caused by Hyperosmolarity

(2008) Oak Z. Chi et al.   PHARMACOLOGY

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

(2007) Joseph D. Raffetto et al.   BIOCHEMICAL PHARMACOLOGY